Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep

R. Pérez, C. Palma, M. J. Núñez, J. Cox, M. Arboix

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


The plasma kinetic profile of ivermectin during the last trimester of pregnancy was studied in ewes after a single subcutaneous administration of 0.2 mg/kg body weight (BW). Sheep were randomly distributed into two groups. Ewes in group 1 (control, n = 6) were left unmated, whereas in group 2 (pregnant, n = 6) ewes were estrus-synchronized and mated with rams. Both groups were housed under similar conditions of management and feeding. At 120 days of pregnancy, both groups were given a subcutaneous injection of 0.2 mg/kg BW of ivermectin. Blood samples were taken by jugular puncture according to a fixed protocol between 1 h and 40 days post-treatment. After plasma extraction and derivatization, samples were analyzed by high performance liquid chromatography with fluorescence detection. A computerized pharmacokinetic analysis was performed, and the data were compared by means of the Student t-test. The results showed that plasma concentrations of ivermectin remained longer in the pregnant than in the control group. The mean values of pharmacokinetic parameters Cmax, tmax, and area under the concentration-time curve (AUC) were similar for both groups of sheep. The mean residence time (MRT) values for the pregnant group (8.8 ± 1.4 days) were higher (P < 0.05) than those observed in the control group (5.3 ± 1.9 days). It can be concluded that pregnancy increases the residence time of ivermectin in the plasma of pregnant sheep when it is administered subcutaneously. © 2007 The Authors.
Original languageEnglish
Pages (from-to)71-76
JournalJournal of Veterinary Pharmacology and Therapeutics
Issue number1
Publication statusPublished - 1 Feb 2008


Dive into the research topics of 'Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep'. Together they form a unique fingerprint.

Cite this